- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 22
  num_fold: 3733
  S: 2985
  I: 664
  R: 84
  median_fold: 1.8
  percent: 8.3
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 17
  num_fold: 558
  S: 412
  I: 124
  R: 22
  median_fold: 2.5
  percent: 1.2
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 140
  num_fold: 15226
  S: 11587
  I: 2853
  R: 786
  median_fold: 2.3
  percent: 34.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 30
  num_fold: 1048
  S: 701
  I: 296
  R: 51
  median_fold: 2.8
  percent: 2.3
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 33
  num_fold: 1648
  S: 1100
  I: 431
  R: 117
  median_fold: 4.0
  percent: 3.7
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 3
  num_fold: 61
  S: 28
  I: 26
  R: 7
  median_fold: 6.1
  percent: 0.14
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.35
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.031
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 55
  num_fold: 5220
  S: 3669
  I: 1282
  R: 269
  median_fold: 2.3
  percent: 12.0
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 6
  num_fold: 333
  S: 241
  I: 73
  R: 19
  median_fold: 3.0
  percent: 0.74
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 14
  num_fold: 697
  S: 412
  I: 263
  R: 22
  median_fold: 4.2
  percent: 1.6
  priority: 2
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 6
  num_fold: 652
  S: 222
  I: 177
  R: 253
  median_fold: 12.0
  percent: 1.5
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 19
  S: 18
  I: 1
  R: 0
  median_fold: 2.7
  percent: 0.042
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 27
  num_fold: 1530
  S: 923
  I: 459
  R: 148
  median_fold: 4.1
  percent: 3.4
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 8
  num_fold: 230
  S: 190
  I: 38
  R: 2
  median_fold: 1.6
  percent: 0.51
  priority: 3
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 137
  S: 93
  I: 35
  R: 9
  median_fold: 4.0
  percent: 0.31
  priority: 3
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 459
  S: 224
  I: 114
  R: 121
  median_fold: 5.2
  percent: 1.0
  priority: 6
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 32
  S: 24
  I: 6
  R: 2
  median_fold: 2.8
  percent: 0.071
  priority: 6
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 28
  S: 20
  I: 8
  R: 0
  median_fold: 4.4
  percent: 0.063
  priority: 6
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 81
  S: 70
  I: 11
  R: 0
  median_fold: 1.3
  percent: 0.18
  priority: 7
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 5
  num_fold: 224
  S: 183
  I: 37
  R: 4
  median_fold: 1.5
  percent: 0.5
  priority: 8
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 419
  S: 100
  I: 26
  R: 293
  median_fold: 48.0
  percent: 0.94
  priority: 8
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 1.1
  priority: 9
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 172
  S: 152
  I: 0
  R: 20
  median_fold: 2.4
  percent: 0.38
  priority: 9
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 134
  S: 134
  I: 0
  R: 0
  median_fold: 4.3
  percent: 0.3
  priority: 10
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 11
  num_fold: 1467
  S: 985
  I: 468
  R: 14
  median_fold: 3.9
  percent: 3.3
  priority: 10
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 1094
  S: 574
  I: 520
  R: 0
  median_fold: 3.6
  percent: 2.4
  priority: 10
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 148
  S: 110
  I: 34
  R: 4
  median_fold: 2.3
  percent: 0.33
  priority: 11
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 64
  S: 40
  I: 24
  R: 0
  median_fold: 2.0
  percent: 0.14
  priority: 13
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 6
  num_fold: 459
  S: 311
  I: 106
  R: 42
  median_fold: 2.7
  percent: 1.0
  priority: 14
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 15
  num_fold: 852
  S: 666
  I: 124
  R: 62
  median_fold: 2.4
  percent: 1.9
  priority: 15
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 4
  num_fold: 141
  S: 99
  I: 37
  R: 5
  median_fold: 2.6
  percent: 0.31
  priority: 15
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 306
  S: 196
  I: 109
  R: 1
  median_fold: 3.6
  percent: 0.68
  priority: 15
- vaccine: mRNA-1273 + mRNA-1273.351
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 237
  S: 222
  I: 11
  R: 4
  median_fold: 2.2
  percent: 0.53
  priority: 18
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 13
  S: 0
  I: 10
  R: 3
  median_fold: 15.0
  percent: 0.029
  priority: 25
- vaccine: BNT162b2 or AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 38
  S: 30
  I: 7
  R: 1
  median_fold: 3.2
  percent: 0.085
  priority: 26
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 70
  S: 42
  I: 28
  R: 0
  median_fold: 2.3
  percent: 0.16
  priority: 31
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 91
  S: 39
  I: 48
  R: 4
  median_fold: 5.2
  percent: 0.2
  priority: 34
